openPR Logo
Press release

Protein and Peptide-Based Therapeutics Trending the Global Orally Disintegrating Tablets Market

02-26-2019 12:37 PM CET | Health & Medicine

Press release from: Persistence Market Research pvt ltd

Protein and Peptide-Based Therapeutics Trending the Global

In a new report titled ‘Orally Disintegrating Tablets Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,’ Persistence Market Research studies the performance of the global orally disintegrating tablets market over an eight year period from 2017 to 2025 and presents a detailed forecast of the market both for the historical period 2012 – 2016 as well as for the forecasted period of 2017 – 2025. According to Persistence Market Research, the global orally disintegrating tablets market is predicted to grow at a significant pace during the assessment period owing to a rising preference for orally disintegrating tablets among patients and physicians alike; coupled with the fact that orally disintegrating tablets minimize the scope for dosage errors and are ideal for administering to patients of all age groups. These factors are likely to boost revenue growth of the global orally disintegrating tablets market, which is anticipated to rise from an estimated US$ 11.4 Bn in 2017 to about US$ 27 Bn by the end of 2025, witnessing a CAGR of 11.5% in terms of value during the forecast period.

To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/14572

In this report, Persistence Market Research segments the global orally disintegrating tablets market on the basis of drug class, disease indication, distribution channel, and region.

Global Orally Disintegrating Tablets Market, Forecast by Drug Class

In terms of drug class, the global orally disintegrating tablets market is further segmented into Anti-Psychotics, Anti-Epileptics, CNS Stimulants, Anxiolytics, Anti-Parkinsonian Drugs, Anti-Hypertensives, NSAIDS, Anti-Allergy Drugs, Proton Pump Inhibitor, and Others. Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight year period.

Global Orally Disintegrating Tablets Market, Forecast by Disease Indication

Under this category, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases, Allergy, and Others. CNS Diseases segment will hold maximum revenue share in the global market, and Persistence Market Research forecasts indicate a 55% market share for this segment by the end of the forecast period in 2025. The CNS Diseases segment is forecasted to reach a market valuation of about US$ 15 Bn by 2025 end, registering a CAGR of 13.2%. This is slated to be the most dominant segment by disease indication in the global orally disintegrating tablets market.

Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/14572

Global Orally Disintegrating Tablets Market, Forecast by Distribution Channel

Of the various distribution channels of orally disintegrating tablets viz., Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies, Hospital Pharmacies will be the undisputed leader in terms of market share throughout the forecast period, anticipated to account for nearly 49% value share by the end of 2025. A market valuation of about US$ 13 Bn by the end of 2025 with a 13.2% CAGR is likely to be in store for this segment.

Global Orally Disintegrating Tablets Market, Regional Forecast

Persistence Market Research tracks the performance of the global orally disintegrating tablets market across the key geographies of North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is slated to dominate the global market throughout the forecast period, with an estimated 35% market share and a market value of about US$ 9.7 Bn by the end of 2025. This is reflective of a CAGR of 11.7% during the forecast period.

Get full Report Now: https://www.persistencemarketresearch.com/checkout/14572

Global Orally Disintegrating Tablets Market, Vendor Ecosystem

The report profiles some of the leading companies operating in the global orally disintegrating tablets market such as Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca, Mylan N.V., Pfizer Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Valeant, GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Bayer AG, Eli Lilly and Company, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Zydus Cadila, NEOS Therapeutics, Inc., Glenmark, and Unichem Laboratories.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Protein and Peptide-Based Therapeutics Trending the Global Orally Disintegrating Tablets Market here

News-ID: 1617477 • Views: 205

More Releases from Persistence Market Research pvt ltd

Osteoarthritis Treatment Market Analysis By 2025 | Top Key Players are Johnson & …
Persistence Market Research (PMR) has published a new research report on the osteoarthritis treatment market titled “Osteoarthritis Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” An alarming rise in the number of osteoarthritis cases is the result of a growing geriatric population worldwide. In order to cater to the needs of the rapidly increasing geriatric population as well as the female population – given that osteoarthritis prevails mostly among
Soft Tissue Repair Market Opportunity By 2024 | Top Key Players are Baxter, B. B …
Soft tissue repair is a process of replacement of destroyed or injured tissue by healthy tissue. One of the key factors driving the market is the rise in a number of accidents and accidental injuries. This is leading to the soft tissue injuries in ligaments, muscle, and tendons. Soft tissue injuries are being treated with soft tissue fixation devices and scaffolds. Increasing number of sports injuries is also driving the
Biosensor Market Forecast By 2020 | Top Key Players are Abbott Laboratories, Inc …
According to a new market report published by Persistence Market Research “Global Market Study on Biosensor: Asia-Pacific to Witness Highest Growth by 2020,” the global biosensor market was valued at USD 12,963.6 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 22,551.2 million in 2020. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/3589 Globally, the
Growing Usage in Non-medical Sectors to Create Promising Prospects for Medical & …
Persistence Market Research has estimated the global market for medical & industrial gloves at US$ 12,868.6 Mn by the end of 2026, exhibiting robust expansion at a CAGR of 7.9% over 2018–2026. According to the latest market outlook released by the company, the global Medical & Industrial Gloves Market holds promising growth prospects over the next eight years. The market will benefit from multiple innovations through intense research and

All 5 Releases


More Releases for Disintegrating

Orally Disintegrating Tablet (ODT) Market: Competitive Dynamics & Global Outlook …
New report published by Market Research Report Store (MRRS) which offers insights on the global Orally Disintegrating Tablet (ODT) market. An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative
Disintegrating Agent Market Bolstered by Emerging New Advancements, Says QYR
The disintegrant refers to a substance which can rapidly break up a tablet into fine particles in a gastrointestinal fluid, thereby allowing the functional ingredient to rapidly dissolve and absorb and function. Most of the disintegrants have good water absorption and swelling properties, thereby achieving disintegration of the tablets. In addition to sustained-release tablets and certain special-purpose tablets, a disintegrating agent should be added to a general tablet. In 2018, the market
Disintegrating Agents Market Outlook and Growth Report | 2025
Disintegrating agents are chemical agents consisting of a mixture of substances or a single substance that are added to tablets and other encapsulated formulations to facilitate disintegration of the capsule or tablet into smaller remains for better discharge of the drug in the body. This process helps provide better results of the drug on the body. Disintegrating agents primarily find application in the pharmaceutical industry. These agents are used in
Global Orally Disintegrating Tablet Market Growth Analysis
Qyresearchreports include new market research report Global Orally Disintegrating Tablet Sales Market Report 2018 to its huge collection of research reports. The global Orally Disintegrating Tablet market has been explained in details in the report. It offers various crucial statistics pertaining to the revenue, products and applications, and geography of the market. Apart from that, the report also collates information on the different macro-fundamentals and other factors promoting or hindering the
Orally Disintegrating Tablets Market Analysis & Trends 2025
In a new report titled ‘Orally Disintegrating Tablets Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,’ Persistence Market Research studies the performance of the global orally disintegrating tablets market over an eight year period from 2017 to 2025 and presents a detailed forecast of the market both for the historical period 2012 – 2016 as well as for the forecasted period of 2017 – 2025. According
Orally Disintegrating Tablet Market with Current Trends Analysis, 2017-2025
Drug delivery systems are becoming progressively sophisticated as pharmaceutical researchers obtain a good understanding of the biochemical and physiological parameters pertinent to their performance. The drug delivery through oral route is the standard technique in the pharmaceutical industry as it is considered as the most economic, convenient, and safest route of drug administration. The oral tablets are usually taken with water only with an exclusion of orally disintegrating tablets and